Richmond, Virginia, September 30, 2013 - avVaa World Health Care Products ("the Company") ("avVaa" or "the Company") (Pink Sheets: AVVH) AVVAA would like to announce it will be expanding its line of Neuroskin products beginning this fall with the initial introduction of 3 new products.
In its biologically active "amorphous" form, silica plays an important role in the growth and development of collagen, which in turn provides skin with firmness, elasticity and strength. Unlike other products currently on the market today containing silica ingredients, Neuroskin contains biologically active silicon dioxide. This is because the silica is broken down to a very tiny or "nano-particle" level. This patented nanotechnology allows the silica to be absorbed into the skin while maintaining its biologic properties.
The first product, Neuroskin High Intensity Moisturizer, will optimize and intensify a natural healthy looking skin. This product will be delivered in a spray format much like our current signature Neuroskin products and be available to order this fall.
The second product to be introduced this fall will be Neuroskin Pure Microdermabrasion skin resurfacing. This is a technique for removing the topmost layer of the skin leaving it supple and vibrant. Skin exfoliation is a wonderful alternative to laser or chemical peels.
Finally, we will introduce Neuroskin Anti-Aging Facial Cream which contains micronized silica that assists in reducing and smoothening face and neck wrinkles.
"It is a great time to be a part of this company and I am excited about expanding the Neuroskin product line. We have been busy developing what we feel to be far superior products to others currently in the marketplace," said Jason Price, Avvaa’s Chairman and CEO. "These new products are just a small fraction of what is in the product pipeline we will adding to the Neuroskin brand in the future."
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin® line of skin care products through mass food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.
Jason Price Chairman & CEO
avVaa World Health Care Products
Pink Sheets: AVVH
This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
Leave a comment...